Impact of Kidney Function on the Blood Proteome and on Protein Cardiovascular Risk Biomarkers in Patients With Stable

Joseph Yang1,2, Edward N Brody3, Ashwin C Murthy3

  • 1Division of Cardiology Department of Medicine University of California, San Francisco CA.

Insights

Chronic kidney disease (CKD) significantly alters blood proteins, impacting cardiovascular risk. New protein biomarkers predict cardiovascular events in CKD patients, some unique to this population.

Area of Science:

  • Proteomics
  • Nephrology
  • Cardiology

Background:

  • Chronic kidney disease (CKD) is a significant risk factor for cardiovascular disease (CVD), beyond traditional risk factors.
  • Plasma proteins play crucial roles in biological processes and disease risk stratification.
  • Understanding the proteomic changes in CKD is vital for improving cardiovascular risk prediction.

Purpose of the Study:

  • To investigate how reduced kidney function (glomerular filtration) affects the circulating proteome.
  • To assess the prognostic value of known protein biomarkers for cardiovascular risk in the context of kidney function.
  • To identify novel and CKD-specific protein biomarkers for cardiovascular risk.

Main Methods:

  • Quantified 1054 plasma proteins in 938 stable coronary heart disease patients using SOMAscan.
  • Correlated plasma protein levels with estimated glomerular filtration rate (eGFR).
  • Employed Cox proportional hazard models to assess protein-outcome associations and cardiovascular risk.

Main Results:

  • A majority of plasma proteins (67.3%) showed correlation with eGFR; 20.7% demonstrated moderate to strong correlation.
  • Of 196 previously identified protein biomarkers, only 87 retained prognostic significance after adjusting for eGFR.
  • Identified 21 protein biomarkers for cardiovascular risk in CKD patients, with 8 being unique to this group.

Conclusions:

  • Chronic kidney disease profoundly impacts the circulating proteome.
  • Protein biomarkers can predict cardiovascular risk independently of kidney function.
  • Specific protein biomarkers offer prognostic value for cardiovascular risk uniquely in CKD patients.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
412
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
246
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
436
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
659
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
190
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
427